Skip to main content

Advertisement

Log in

Life-Threatening Complications of Hepatitis B Virus-Related Polyarteritis Nodosa Developing Despite Interferon-α2b Therapy: Successful Treatment with a Combination of Interferon, Lamivudine, Plasma Exchanges and Steroids

  • Case Report
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

Polyarteritis nodosa (PAN) is a rare vasculitis associated with hepatitis B virus (HBV) infection in a significant proportion of cases. When used to treat HBV-related PAN, immunosuppressive agents may enhance viral replication and relaspes are frequent. In recent years the use of antiviral drugs has been proposed. We report the case of a patient with HBV-related PAN who, despite 6 weeks of interferon-α2b (IFN-α2b) monotherapy, developed life-threatening complications with bowel perforation. He was thereafter successfully treated with a combination of IFN-α2b, lamivudine, plasma exchanges and short-term steroids. In contrast to IFN-α2b, lamivudine is effective in rapidly suppressing viral replication. This may be valuable in the treatment of HBV-related PAN by contributing to a faster diminution of circulating immune complex levels. This case report highlights the importance of aggressive combined therapy in patients with HBV-related PAN.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Additional information

Received: 2 June 2000 / Accepted: 19 January 2001

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dele´aval, P., Stadler, P., Descombes, E. et al. Life-Threatening Complications of Hepatitis B Virus-Related Polyarteritis Nodosa Developing Despite Interferon-α2b Therapy: Successful Treatment with a Combination of Interferon, Lamivudine, Plasma Exchanges and Steroids. Clin Rheumatol 20, 290–292 (2001). https://doi.org/10.1007/s100670170050

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s100670170050

Navigation